Position in UPB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$26,078,843
-$52,185,023 QoQ
Shares Held
3,768,619
+30.7% QoQ
Ownership
6.88%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 148 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UPB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. UPB ranks #31 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,971,681 | $1,476,123,103 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,172,808 | $731,292,700 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,271,813 | $683,883,867 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
8,207,954 | $469,659,127 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,157,479 | $404,052,667 | |
| 6 | INSM |
INSMED Inc
|
3,377,641 | $360,124,083 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,896,536 | $317,606,649 | |
| 8 | RPRX |
Royalty Pharma plc
|
5,336,084 | $299,194,229 |
All Filings in UPB
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,078,843 | 3,768,619 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $78,263,866 | 2,882,647 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $10,649,677 | 969,916 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,935,885 | 969,916 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $16,440,000 | 1,000,000 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||